Michael Linenberger, M.D.

Michael Linenberger M.D.
faculty member

Michael Linenberger, M.D.

Clinical Research Division, Fred Hutch

Fax: 206.667.5899
Mail Stop: D5-280

Dr. Michael Linenberger is a hematologist who treats patients with blood cancers such as leukemia, lymphoma, myeloproliferative neoplasms and myelodysplastic syndromes, or blood disorders such as anemia, sickle cell disease, thrombosis and bleeding. His research focuses on apheresis, the procedure for removing specific cell types from blood. He is an expert in bone marrow and peripheral blood stem cell procurement for transplantation, collection of immune effector cells, and safety issues for patients and recipients of cell-based therapies. At Fred Hutch, he is the chief medical director of the Cell Processing Facility and medical director of Apheresis and Cellular Therapy and the collection center for the National Marrow Donor Program. He is actively involved in teaching at the University of Washington and Fred Hutch, where he directs the adult Hematology/Oncology Fellowship Program.

Other Appointments & Affiliations

Program Director, Hematology/Oncology Fellowship
University of Washington

Medical Director, Apheresis and Cellular Therapy
Fred Hutchinson Cancer Center

Professor, Hematology
University of Washington

Robert and Phyllis Henigson Endowed Chair
University of Washington


M.D., University of Kansas, Kansas City, 1982

B.S., University of Kansas, 1978

Current Projects

A Multicenter Study of Hematopoietic Stem Cell Donor Safety and Quality of Life Cancer Center Support Grant, Adult Leukemia Research Center

Institutional and multicenter projects supported by the Cancer Center Support Grant, Acute Leukemia Research

Find A Clinical Trial

Dr. Linenberger in the News

Attending with compassionate care

Hutch News - March 17, 2005

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email media@fredhutch.org or call 206.667.2210